Advanced search
Publication Cover
Leukemia & Lymphoma Volume 18, 1995 - Issue 5-6
Submit an article Journal homepage
24
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Low-Dose Cytosine Arabinoside in Patients with Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy

A. Pascarella Division of Hematology, Policlinico di Careggi, University of Florence, Florence, Italy
,
C. Marrani Division of Hematology, Policlinico di Careggi, University of Florence, Florence, Italy
,
F. Leoni Division of Hematology, Policlinico di Careggi, University of Florence, Florence, Italy
,
S. Ciolli Division of Hematology, Policlinico di Careggi, University of Florence, Florence, Italy
,
C. Nozzoli Division of Hematology, Policlinico di Careggi, University of Florence, Florence, Italy
,
R. Caporale Division of Hematology, Policlinico di Careggi, University of Florence, Florence, Italy
,
F. Salti Division of Hematology, Policlinico di Careggi, University of Florence, Florence, Italy
&
P. Rossi Ferrini Division of Hematology, Policlinico di Careggi, University of Florence, Florence, Italy
 show all
Pages 465-469 | Received 24 Oct 1994, Published online: 01 Jul 2009

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lance H. Leopold & Roel Willemze. (2002) The Treatment of Acute Myeloid Leukemia in First Relapse: A Comprehensive Review of the Literature. Leukemia & Lymphoma 43:9, pages 1715-1727.
Read now
Toshiyuki Bohgaki, Atsushi Notoya, Makoto Kondo, Masaya Mukai & Michifumi Kohno. (2001) Leukemia Cutis in an Elderly Patient Treated with Low Dose Cytosine Arabinoside and Etoposide. Leukemia & Lymphoma 40:3-4, pages 433-436.
Read now

Articles from other publishers (2)

Zhen-yi Wang. (2003) Ham-Wasserman Lecture. Hematology 2003:1, pages 1-13.
Crossref
C Robles, KM Kim, MM Oken, JM Bennett, L Letendre, PH Wiernik, MJ O'Connell & PA Cassileth. (2000) Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483). Leukemia 14:8, pages 1349-1353.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.